The Remaining “To Do” List on Patent Reform: Consolidation and Optimization

Vol. 4 No. 5

By

Robert A. Armitage is chair of the ABA Section of Intellectual Property Law. He serves as senior vice president and general counsel at Eli Lilly and Company in Indianapolis, Indiana. He can be reached at armitage_robert_a@lilly.com.

The United States Patent and Trademark Office (USPTO) is marching along with the immense efforts needed to complete regulations to implement the Leahy-Smith America Invents Act (AIA). Within the patent profession—notably within the Patent Division of the ABA Section of Intellectual Property Law—there have  been prolific and heroic efforts to assist the USPTO in the rule writing needed to bring the AIA to life.

If there is one oft-expressed hope of many participants in the AIA’s legislative and regulatory phases, it is that successful conclusion of these efforts will yield a sustained period of reflection. “No New Patent Laws!”—at least not until the new law now on the books is digested and its impacts, for better or worse, are more fully understood.

Premium Content for:

  • ABA Section of Intellectual Property Law Members
Join Now

Already a member? Log In


Advertisement

PatentPak: a CAS Solution. Locate a chemical substance of interest within a full-text patent in seconds with PatentPak(TM)! PatentPak in STN(R) radically reduces the time it takes to track down hard-to-find chemistry within patents. Learn more button. CAS. A division of the American Chemical Society. STN.

 

 

 

Supreme Court Update

by Tom Stoll

 

 Download a printable PDF of this article.

 

April 2017 Webinar: Identifying and Resolving Ethical Conflicts of Interest in Patent Prosecution

 

Coming soon: Copyright Litigation Strategies book

 

  • About LANDSLIDE

  • Subscriptions

  • More Information

  • Contact Us

Advancing Intellectual Property Law®